, from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation
, Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc
Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio, GE Healthcare; IXICO Ltd ,
NeuroRx Research Neurotrack Technologies Novartis Pharmaceuticals Corporation Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org) The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California We thank the International Genomics of Alzheimer's Project (IGAP) for providing summary results data for these analyses. The investigators within IGAP contributed to the design and implementation of IGAP and/or provided data but did not participate in analysis or writing of this report. IGAP was made possible by the generous participation of the control subjects, the patients, and their families. The i?Select chips was funded by the French National Foundation on Alzheimer's disease and related disorders. EADI was supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant, Inserm, Alzheimer's Research UK (Grant n 503176), the Wellcome Trust German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) grant n 01GI0102, 01GI0711, 01GI0420. CHARGE was partly supported by the NIH/NIA grant R01 AG033193 and the NIA AG081220 and AGES contract N01?AG?12100, the NHLBI grant R01 HL105756, the Icelandic Heart Association, and the Erasmus Medical Center and Erasmus University. ADGC was supported by the NIH/NIA grants: U01 AG032984, U24 AG021886, U01 AG016976, and the Alzheimer's Association grant ADGC?10, 196728. ,
, P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), pp.50-016574
Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health The data used for the analyses described in this manuscript were obtained from: the GTEx Portal on 08, 2017. ,
, References
Genetic effects on gene expression across human tissues, Nature, vol.10, issue.7675, pp.204-217, 2017. ,
DOI : 10.1214/16-AOAS952
GENOME-WIDE POLYGENIC RISK FOR ALZHEIMER???S DISEASE IS ASSOCIATED WITH RATE OF METABOLIC DECLINE BUT NOT WITH RATE OF AMYLOID DEPOSITION, Alzheimer's & Dementia, vol.12, issue.7, pp.5-6, 2016. ,
DOI : 10.1016/j.jalz.2016.06.067
Integrating common and rare genetic variation in diverse human populations, Nature, vol.467, pp.52-60, 2010. ,
Adjusting for Heritable Covariates Can Bias Effect Estimates in Genome-Wide Association Studies, The American Journal of Human Genetics, vol.96, issue.2, pp.329-368, 2015. ,
DOI : 10.1016/j.ajhg.2014.12.021
An atlas of genetic correlations across human diseases and traits, Nature Genetics, vol.467, issue.11, pp.1236-1277, 2015. ,
DOI : 10.1038/nature09298
Geodesic Information Flows: Spatially-Variant Graphs and Their Application to Segmentation and Fusion, IEEE Transactions on Medical Imaging, vol.34, issue.9, pp.1976-88, 2015. ,
DOI : 10.1109/TMI.2015.2418298
Second-generation PLINK: rising to the challenge of larger and richer datasets, GigaScience, vol.30, issue.1, p.7, 2015. ,
DOI : 10.1093/bioinformatics/btu495
Improved ancestry inference using weights from external reference panels, Bioinformatics, vol.82, issue.11, pp.1399-406, 2013. ,
DOI : 10.1016/j.ajhg.2007.10.009
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration, Proceedings of the National Academy of Sciences, vol.81, issue.2, pp.7401-7407, 2010. ,
DOI : 10.1086/519497
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer???s Disease, Neuron, vol.78, issue.2, pp.256-68, 2013. ,
DOI : 10.1016/j.neuron.2013.02.026
Epidemiological Approaches to Heart Disease: The Framingham Study, American Journal of Public Health and the Nations Health, vol.41, issue.3, pp.279-86, 1951. ,
DOI : 10.2105/AJPH.41.3.279
A linear complexity phasing method for thousands of genomes, Nature Methods, vol.165, issue.2, pp.179-81, 2011. ,
DOI : 10.1086/500808
A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin, Neurobiol Aging, vol.37, pp.208-209, 2016. ,
Estimating long-term multivariate progression from short-term data, Alzheimer's & Dementia, vol.10, issue.5, pp.400-410, 2014. ,
DOI : 10.1016/j.jalz.2013.10.003
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease, Neurology, vol.72, issue.17, pp.1487-94, 2009. ,
DOI : 10.1212/WNL.0b013e3181a2e8d0
Gene expression correlates of neurofibrillary tangles in Alzheimer's disease, Neurobiology of Aging, vol.27, issue.10, pp.1359-71, 2006. ,
DOI : 10.1016/j.neurobiolaging.2005.08.013
Efficient haplotype matching and storage using the positional Burrows-Wheeler transform (PBWT), Bioinformatics, vol.23, issue.5, pp.1266-72, 2014. ,
DOI : 10.1093/bioinformatics/btl681
A map of human genome variation from population-scale sequencing, Nature, vol.10, issue.7319, pp.1061-73, 2010. ,
DOI : 10.1038/nature09534
URL : https://hal.archives-ouvertes.fr/cea-00904997
Common polygenic variation enhances risk prediction for Alzheimer???s disease, Brain, vol.70, issue.12, pp.3673-84, 2015. ,
DOI : 10.1016/S0022-3956(02)00020-1
A multivariate test of association, Bioinformatics, vol.81, issue.1, pp.132-135, 2009. ,
DOI : 10.1086/519795
A Proportional Hazards Model for the Subdistribution of a Competing Risk, Journal of the American Statistical Association, vol.69, issue.446, pp.496-509, 1999. ,
DOI : 10.1093/biomet/69.1.239
Whole Brain Segmentation, Neuron, vol.33, issue.3, pp.341-55, 2002. ,
DOI : 10.1016/S0896-6273(02)00569-X
An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease, NeuroImage, vol.60, issue.3, pp.1880-1889, 2012. ,
DOI : 10.1016/j.neuroimage.2012.01.062
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants, Nature Genetics, vol.119, issue.2, pp.134-177, 2016. ,
DOI : 10.1002/gepi.20579
XWAS: A Software Toolset for Genetic Data Analysis and Association Studies of the X Chromosome, Journal of Heredity, vol.129, issue.5, pp.666-71, 2015. ,
DOI : 10.1002/gepi.20244
A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms, Genetic Epidemiology, vol.70, issue.4, pp.361-370, 2008. ,
DOI : 10.1093/oxfordjournals.aje.a009878
Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo, The EMBO Journal, vol.34, issue.8, pp.1056-77, 2015. ,
DOI : 10.15252/embj.201488796
The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods, Journal of Magnetic Resonance Imaging, vol.6, issue.4, pp.685-91, 2008. ,
DOI : 10.1201/9781420042474
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, The Lancet Neurology, vol.12, issue.2, pp.207-223, 2013. ,
DOI : 10.1016/S1474-4422(12)70291-0
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, The Lancet Neurology, vol.9, issue.1, pp.119-147, 2010. ,
DOI : 10.1016/S1474-4422(09)70299-6
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core, Alzheimer's & Dementia, vol.6, issue.3, pp.221-230, 2010. ,
DOI : 10.1016/j.jalz.2010.03.003
Analysis of Synapsin III ???196 Promoter Mutation in Schizophrenia and Bipolar Disorder, Neuropsychobiology, vol.10, issue.2, pp.57-62, 2006. ,
DOI : 10.1001/archpsyc.1978.01770310043002
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease, Nature Genetics, vol.9, issue.12, pp.1452-1460, 2013. ,
DOI : 10.1093/bioinformatics/btq419
Measurement of Longitudinal ??-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios, Journal of Nuclear Medicine, vol.56, issue.4, pp.567-74, 2015. ,
DOI : 10.2967/jnumed.114.148981
Genotype imputation for genome-wide association studies, Nature Reviews Genetics, vol.42, issue.7, pp.499-511, 2010. ,
DOI : 10.1214/09-STS311
A new multipoint method for genome-wide association studies by imputation of genotypes, Nature Genetics, vol.164, issue.7, pp.906-919, 2007. ,
DOI : 10.1038/nrg1916
A reference panel of 64,976 haplotypes for genotype imputation, Nat Genet, vol.48, pp.1279-83, 2016. ,
DOI : 10.1101/035170
The Ensembl Variant Effect Predictor, Genome Biology, vol.42, issue.8, p.122, 2016. ,
DOI : 10.1093/nar/gku1206
MultiPhen: joint model of multiple phenotypes can increase discovery in GWAS, PLoS One, vol.7, p.34861, 2012. ,
Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients, Multiple Sclerosis Journal, vol.6, issue.1, pp.124-132, 2009. ,
DOI : 10.1177/1352458506070454
Reconstructing a 3D structure from serial histological sections, Image and Vision Computing, vol.19, issue.1-2, pp.25-31, 2001. ,
DOI : 10.1016/S0262-8856(00)00052-4
URL : https://hal.archives-ouvertes.fr/cea-00333669
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status, Acta Neuropathologica, vol.34, issue.2890, pp.925-958, 2016. ,
DOI : 10.1523/JNEUROSCI.1860-14.2014
Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease, PLoS ONE, vol.19, issue.8, p.6501, 2009. ,
DOI : 10.1371/journal.pone.0006501.s040
World Alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. London: Alzheimer's Disease International, 2015. ,
LocusZoom: regional visualization of genome-wide association scan results, Bioinformatics, vol.26, issue.7, pp.2336-2343, 2011. ,
DOI : 10.1093/bioinformatics/btq068
R: a language and environment for statistical computing. The R Foundation for Statistical Computing, 2005. ,
, Brain, vol.11, issue.10, pp.3076-88, 2015.
DOI : 10.1073/pnas.1322563111
APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study, Molecular Psychiatry, vol.23, issue.3, pp.351-358, 2014. ,
DOI : 10.1093/brain/awn016
Genetic variability in the regulation of gene expression in ten regions of the human brain, Nature Neuroscience, vol.57, issue.10, pp.1418-1446, 2014. ,
DOI : 10.1093/nar/gkp942
Dementia of the eye: the role of amyloid beta in retinal degeneration, Eye, vol.40, issue.8, pp.1013-1039, 2015. ,
DOI : 10.1042/BJ20121773
, GWAS of Alzheimer's disease progression score BRAIN, pp.141-2167, 2018.
Reconstructing Native American population history, Nature, vol.21, issue.7411, pp.370-374, 2012. ,
DOI : 10.1093/bioinformatics/bti282
URL : https://hal.archives-ouvertes.fr/hal-00726962
Impact of pre-imputation SNP-filtering on genotype imputation results, BMC Genetics, vol.35, issue.1, p.88, 2014. ,
DOI : 10.1002/gepi.20552
Association of apolipoprotein E allele ??4 with late-onset familial and sporadic Alzheimer's disease, Neurology, vol.43, issue.8, pp.1467-72, 1993. ,
DOI : 10.1212/WNL.43.8.1467
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans, Alzheimer's & Dementia, vol.6, issue.3, pp.265-73, 2010. ,
DOI : 10.1016/j.jalz.2010.03.013
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers, Brain, vol.17, issue.1, pp.1067-77, 2008. ,
DOI : 10.1016/0022-3956(82)90033-4
Regression modeling of competing risk using R: an in depth guide for clinicians, Bone Marrow Transplantation, vol.6, issue.9, pp.496-509, 2010. ,
DOI : 10.1038/sj.bmt.1703271
Imputation-based analysis of association studies: candidate regions and quantitative traits, PLoS Genet, vol.3, pp.1296-308, 2007. ,
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort, NeuroImage, vol.53, issue.3, pp.1051-63, 2010. ,
DOI : 10.1016/j.neuroimage.2010.01.042
Voxelwise genome-wide association study (vGWAS), NeuroImage, vol.53, issue.3, pp.1160-74, 2010. ,
DOI : 10.1016/j.neuroimage.2010.02.032
STRING v10: protein???protein interaction networks, integrated over the tree of life, Nucleic Acids Research, vol.1695, issue.D1, pp.447-52, 2015. ,
DOI : 10.1186/gb-2004-5-10-r80
Arf6 controls beta-amyloid production by regulating macropinocytosis of the Amyloid Precursor Protein to lysosomes, Molecular Brain, vol.88, issue.24, p.41, 2015. ,
DOI : 10.1111/j.0953-816X.2004.03349.x
Defining the role of common variation in the genomic and biological architecture of adult human height, Nature Genetics, vol.52, issue.11, pp.1173-86, 2014. ,
DOI : 10.1093/nar/gkr988
??-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons, Journal of Cell Science, vol.128, issue.13, pp.2231-2274, 2015. ,
DOI : 10.1242/jcs.157867